Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Bone|June 23, 2012
A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblastsKim Henriksen, Kim V Andreassen, Christian S Thudium, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemiaHelena Ågerstam, Christine Karlsson, Nils Hansen, et al.
British Journal of Haematology|March 30, 2021
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registryHjalmar Flygt, Fredrik Sandin, Torsten Dahlén, et al.
Blood|September 14, 2016
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft modelsHelena Ågerstam, Nils Hansen, Sofia von Palffy, et al.
Plos One|November 17, 2011
Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strengthKim Henriksen, Carmen Flores, Jesper S Thomsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib TherapyNoortje Thielen, Johan Richter, Matthias Baldauf, et al.
Haematologica|October 5, 2019
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cellsSofia von Palffy, Niklas Landberg, Carl Sandén, et al.
Therapeutic Drug Monitoring|December 24, 2015
In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid LeukemiaKarin Skoglund, Johan Richter, Ulla Olsson-Strömberg, et al.
Blood Advances|January 4, 2018
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cellsMia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, et al.
Journal of Cancer Research and Clinical Oncology|March 25, 2017
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemiaHanna L M Rajala, Mohamed El Missiry, Anniina Ruusila, et al.
Pageof 11